// App-Quantinova.ai

SAT0182 : THE ASSOCIATION BETWEEN AUTOANTIBODIES AND RITUXIMAB RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS

Researchers

Presenter

  • D. Li

Principal Investigators

  • H. Lu

  • J. Dunphy

  • T. Smith

  • E. Vital

  • I. N. Bruce

  • N. Mchugh

Medical Centers

  • University of Bath, Pharmacy and Pharmacology, Bath, United Kingdom

  • Royal United Hospital NHS Foundation Trust, Bath, United Kingdom,

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

  • Leeds Teaching Hospitals NHS Trust and NIHR Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, Greater Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • The Medical Research Council

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved